Refresh

Suven Pharmaceuticals Ltd. - Research Center

543064 SUVENPHAR Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

1,330.08 1,320.22 1,009.72 833.79 377.83
Expenses

Material consumed

402.36 401.55 303.70 230.14 103.74

Manufacturing expenses

168.93 170.74 120.98 104.80 50.77

Personnel expenses

100.84 100.48 87.29 73.72 29.63

Selling expenses

- - - - -

Adminstrative expenses

74.87 67.46 57.23 39.98 22.15

Expenses capitalised

- - - - -

Cost of sales

747.00 740.23 569.20 448.64 206.28

Operating profit

583.08 579.99 440.52 385.15 171.55

Other recurring income

44.55 187.79 14.24 18.12 0.60

Adjusted PBDIT

627.63 767.78 454.76 403.26 172.15

Financial expenses

5.39 6.23 9.14 21.81 2.79

Depreciation

42.84 39.10 31.64 23.86 11.50

Other write offs

- - - - -

Adjusted PBT

579.39 722.45 413.98 357.59 157.87

Tax charges

146.79 164.35 105.33 87.51 48.59

Adjusted PAT

432.60 558.10 308.65 270.08 109.27

Non recurring items

-0.35 -0.76 - -0.82 -

Other non cash adjustments

- - - - -

Reported net profit

432.25 557.34 308.65 269.26 109.27

Earnigs before appropriation

1,708.64 1,393.21 877.17 660.25 429.00

Equity dividend

203.65 101.83 25.46 50.56 15.17

Preference dividend

- - - - -

Dividend tax

- - - 13.08 3.92

Retained earnings

1,504.99 1,291.39 851.71 596.60 409.91
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com